Epistemic institutions; Artificial Intelligence; Economic Growth; Effective Altruism; Research That Will Help Us Improve
Hundreds of existing, low-cost, and widely available generic drugs could be repurposed as effective treatments for additional indications. Yet this major opportunity to improve outcomes for patients suffering from cancer and other diseases while lowering healthcare costs is being ignored due to a market failure. We are interested in funding innovative solutions for bringing repurposed generic drugs to widespread patient use, including:
Methods to identify new uses for existing drugs and gather definitive data more efficiently (e.g., using AI, real-world evidence, and adaptive trial designs).
New ways to fund randomized controlled clinical trials at scale (e.g., using social impact bonds).
Approaches to change the standard of care for patients around the world (e.g., through cross-sector partnerships).
Cheap, lifesaving treatments
Epistemic institutions; Artificial Intelligence; Economic Growth; Effective Altruism; Research That Will Help Us Improve
Hundreds of existing, low-cost, and widely available generic drugs could be repurposed as effective treatments for additional indications. Yet this major opportunity to improve outcomes for patients suffering from cancer and other diseases while lowering healthcare costs is being ignored due to a market failure. We are interested in funding innovative solutions for bringing repurposed generic drugs to widespread patient use, including:
Methods to identify new uses for existing drugs and gather definitive data more efficiently (e.g., using AI, real-world evidence, and adaptive trial designs).
New ways to fund randomized controlled clinical trials at scale (e.g., using social impact bonds).
Approaches to change the standard of care for patients around the world (e.g., through cross-sector partnerships).